Fatal cardiac incident after use of halofantrine

Journal of Travel Medicine

Volumn 7, Issue 4, 2000, Pages 215-216

  Malvy, D ^a   Receveur, M C ^a   Ozon, P ^b   Djossou, F ^a   Le Metayer, Ph ^a   Touze, J E ^c   Longy Boursier, M ^a   Le Bras, M ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b CENTRE HOSPITALIER DE PAU   (France)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HALOFANTRINE;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CASE REPORT; DRUG CONTRAINDICATION; DRUG EFFECT; FATALITY; FEMALE; HUMAN; QT INTERVAL;

EID: 0033848760     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00065     Document Type: Article

References (12)

1. Prolonged Q-T interval with halofantrine
2. Cardiac effect of halofantrine
3. Cardiac complications of halofantrine: A prospective study of 20 patients
4. Prolonged Q-T interval with halofantrine
5. Cardiac effects of standard-dose halofantrine therapy
6. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria
7. Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long Q-T syndrome
8. Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria
9. Measurements of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: A new methodology
10. Fatal cardiac toxicity due to halofantrine without initial prolonged Q-T interval
11. Halofantrine-associated ventricular fibrillation in a young woman with no predisposing Q-Tc prolongation
12. Chloroquine abuse and heart block in Africans